Regulatory news and experts insights.

In response to the public health and environmental challenges posed by endocrine disruptors (EDs), and following two previous national strategies on endocrine disruptors, the French government has unveiled its new roadmap for the next five years with a clear ambition: moving towards “zero exposure to endocrine disruptors”.

Calculating Margins of Safety (MoS) is at the core of cosmetic ingredient safety assessment. On paper, the principle appears simple: comparing a no-effect dose to an estimated exposure in order to verify that a sufficient safety margin exists. In practice, however, things are often far more complex.

The adoption of Directive (EU) 2024/3019 on urban wastewater treatment (UWWTD), published on 12 December 2024, introduces unprecedented requirements for the pharmaceutical industry. Integrated into the EU “Zero Pollution” Action Plan, this legislation imposes stringent management obligations for pharmaceutical residues

CEHTRA is pleased to announce its participation in the SETAC Europe 36th Annual Meeting, taking place from May 19–21, 2026 in Maastricht. During the event, Floriane Demailly and Mylène Léger will present a scientific poster addressing the implementation challenges associated with the new “rapidly biodegradable” criterion introduced under the recast Urban Waste Water Treatment Directive (UWWTD).